NCT00103948View on ClinicalTrials.gov

The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment

PHASE2CompletedINTERVENTIONAL

Enrollment

165

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

February 28, 2007

Conditions

Cognitive Impairment

Interventions

DRUG

Aricept

Trial Locations (4)

5011

Woodville

10016

New York University School of Medicine, New York

29010

Málaga

60152

Jose Biller, M.D., Maywood

All Listed Sponsors

lead

Eisai Limited

INDUSTRY

NCT00103948 - The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment | Biotech Hunter | Biotech Hunter